scholarly journals A Cross-sectional Study of Fixed and Growth Mindset in Adult Peritoneal Dialysis Patients

2021 ◽  
Vol 8 ◽  
pp. 237437352110552
Author(s):  
Rachel B. Fissell ◽  
David Schlundt ◽  
Kerri L. Cavanaugh ◽  
Claudia Mueller ◽  
Ebele M. Umeukeje ◽  
...  
Keyword(s):  
Peritoneal Dialysis ◽  
Self Efficacy ◽  
Convergent Validity ◽  
Cross Sectional Study ◽  
Growth Mindset ◽  
Dialysis Patients ◽  
Cross Sectional ◽  
Home Dialysis ◽  
Targeted Interventions ◽  
New Strategies

Increasing home dialysis prevalence is an international priority. Many patients start peritoneal dialysis, then transition to hemodialysis after complications. New strategies are needed to support modality persistence. Health mindset refers to individual belief about capacity to change to improve health. Mindset was measured in a cross-section of 101 adult peritoneal dialysis patients from April 2019 to June 2020. The Health Mindset Scale was administered to characterize the continuum of fixed vs. growth mindset with respect to health. Health literacy and health self-efficacy were also assessed. Participants were 43% female, 32% African American, and 42% diabetic. Health mindset scores were skewed toward growth (range 3–18), with average (SD) 12.83 (4.2). Growth mindset was strongly associated with health self-efficacy. Adults receiving peritoneal dialysis report health mindset variation. Growth mindset and health self-efficacy correlation suggests measurement of similar constructs, demonstrating convergent validity. The Health Mindset Scale may identify individuals who could benefit from targeted interventions to improve mindset, and foster peritoneal dialysis modality persistence.

Sevelamer Hydrochloride in Peritoneal Dialysis Patients: Results of a Multicenter Cross-Sectional Study

2007 ◽  
Vol 27 (6) ◽  
pp. 697-701 ◽  
Author(s):  
Rosa Ramos ◽  
Francesc Moreso ◽  
Mercè Borras ◽  
Esther Ponz ◽  
Joan M. Buades ◽  
...  
Keyword(s):  
Peritoneal Dialysis ◽  
Ldl Cholesterol ◽  
Density Lipoprotein ◽  
Cross Sectional Study ◽  
Serum Phosphate ◽  
Sectional Study ◽  
C Reactive Protein ◽  
Dialysis Patients ◽  
Cross Sectional ◽  
Reactive Protein

Background Sevelamer hydrochloride is a phosphate binder widely employed in hemodialysis patients. Until now, information about its efficacy and safety in peritoneal dialysis patients has been scarce. Patients and Methods In September 2005 a cross-sectional study of demographic, biochemical, and therapeutic data of patients from 10 peritoneal dialysis units in Catalonia and the Balearic Islands, Spain, was conducted. Results We analyzed data from 228 patients. At the time of the study, 128 patients (56%) were receiving sevelamer. Patients receiving sevelamer were younger ( p < 0.01), showed a longer period of time on dialysis ( p < 0.01), and had a lower Charlson Comorbidity Index ( p < 0.01). Serum calcium and intact parathyroid hormone levels were not different between the two groups, while phosphate levels <5.5 mg/dL were observed more frequently in patients not receiving sevelamer (79% vs 61%, p < 0.01). Serum total cholesterol (167 ± 41 vs 189 ± 42 mg/dL, p < 0.01) and low density lipoprotein (LDL) cholesterol (90 ± 34 vs 109 ± 34 mg/dL, p < 0.01), but not high density lipoprotein cholesterol or triglycerides, were lower in sevelamer-treated patients. Moreover, sevelamer-treated patients displayed a higher serum albumin (38 ± 5 vs 36 ± 4 g/L, p < 0.01) and a lower C-reactive protein (4.9 ± 12.8 vs 8.8 ± 15.7 mg/L, p < 0.01). Blood bicarbonate levels <22 mmol/L were observed more frequently in patients receiving sevelamer (22% vs 5%, p < 0.01). Logistic regression analysis adjusting by confounding variables confirmed that sevelamer therapy was associated with serum total cholesterol <200 mg/dL [relative risk (RR): 2.77, 95% confidence interval (CI): 1.44 – 5.26, p = 0.002] and blood bicarbonate <22 mmol/L (RR: 8.5, 95% CI: 2.6 – 27.0, p < 0.001), but not with serum phosphate >5.5 mg/dL, calcium–phosphate product >55 mg2/dL2, serum albumin <35 g/L, or C-reactive protein >5 mg/L. Conclusions This uncontrolled cross-sectional study in peritoneal dialysis patients showed that sevelamer hydro-chloride treatment allows an adequate serum phosphate level in about 60% of patients and significantly reduces total and LDL-cholesterol levels. Since this treatment is associated with metabolic acidosis in 22% of patients, we recommend close monitoring of bicarbonate levels in this group of patients until the clinical significance of this result is clarified.

scholarly journals Functional Disability in Older Adults Maintained on Peritoneal Dialysis Therapy

2016 ◽  
Vol 36 (1) ◽  
pp. 71-78 ◽  
Author(s):  
Ozkan Ulutas ◽  
Janine Farragher ◽  
Ernest Chiu ◽  
Wendy L. Cook ◽  
Sarbjit V. Jassal
Keyword(s):  
Peritoneal Dialysis ◽  
Daily Living ◽  
Functional Disability ◽  
Functional Performance ◽  
Functional Dependence ◽  
Cross Sectional Study ◽  
Dialysis Therapy ◽  
Timed Up And Go ◽  
Cross Sectional ◽  
Home Dialysis

♦ BackgroundOlder in-center hemodialysis patients have a high burden of functional disability. However, little is known about patients on home chronic peritoneal dialysis (PD). As patients opting for home dialysis are expected to play a greater role in their own dialysis care, we hypothesized that a relatively low number of PD patients would require help with basic self-care tasks (ADL) and instrumental activities of daily living (IADL).♦ MethodsWe used a cross-sectional study design to measure the proportion of patients aged 65 years and older undergoing outpatient PD who needed help with day-to-day activities. Patients living in nursing homes were excluded from the study. Functional dependence in ADL and IADL tasks were measured by the Barthel and Lawton Scales. Physical performance measures used included the timed up-and-go (TUG) test, chair stands and Folstein mini-mental score (MMSE).♦ResultsA total of 74 of 76 (97%) eligible PD patients participated. Patients had a mean age of 76.2 ± 7.5 years. Thirty-six percent had impaired MMSE scores, 69% were unable to stand from a chair without the use of their arms and 51% had abnormal TUG scores. Only 8 patients (11%) were fully independent for both ADL and IADL activities. Dependence in one or more ADL activity was reported by 64% of participants, while 89% reported dependence in one or more IADL.♦ConclusionsImpaired physical and functional performance is common in older patients maintained on PD. Collaborative geriatric-renal programs may be beneficial within the dialysis community.

Fatigue in Peritoneal Dialysis Patients and an Exploration of Contributing Factors: A Cross-Sectional Study

2020 ◽  
Vol 59 (5) ◽  
pp. 1074-1081.e2
Author(s):  
Chong Tian ◽  
Beibei Zhang ◽  
Wangqun Liang ◽  
Qing Yang ◽  
Qianqian Xiong ◽  
...  
Keyword(s):  
Peritoneal Dialysis ◽  
Cross Sectional Study ◽  
Sectional Study ◽  
Dialysis Patients ◽  
Contributing Factors ◽  
Cross Sectional
Sign in / Sign up

Export Citation Format

Share Document